MASS logo

MASS

908 Devices Inc.

$5.91
+$0.21(+3.68%)
55
Overall
60
Value
50
Tech
--
Quality
Market Cap
$244.30M
Volume
746.54K
52W Range
$1.81 - $9.34
Target Price
$10.00

Company Overview

Mkt Cap$244.30MPrice$5.91
Volume746.54KChange+3.68%
P/E Ratio-3.4Open$5.68
Revenue$59.6MPrev Close$5.70
Net Income$-72.2M52W Range$1.81 - $9.34
Div YieldN/ATarget$10.00
Overall55Value60
Quality--Technical50

No chart data available

About 908 Devices Inc.

908 Devices Inc., a commercial-stage technology company. The company provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. It also provides include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.

Sector: Manufacturing
Industry: Other Measuring and Controlling Device Manufacturing

Latest News

Stifel Nicolaus Keeps Their Buy Rating on 908 Devices (MASS)

In a report released today, Daniel Arias from Stifel Nicolaus maintained a Buy rating on 908 Devices, with a price target of $8.00. Arias covers th...

TipRanks Auto-Generated Intelligence Newsdesk12 days ago

Analysts’ Top Healthcare Picks: Harrow Health (HROW), Ardelyx (ARDX)

Christine Brown13 days ago

Masivo Silver Corp. Expands with Acquisition of Cerro Colorado Property

TipRanks Canadian Auto-Generated Newsdesk25 days ago
ABCD
1SymbolPriceChangeVol
2MASS$5.91+3.7%746.54K
3
4
5
6

Get 908 Devices Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.